Reaction Details  Report a problem with these data
Target
Cytochrome P450 3A4
Ligand
BDBM50603089
Substrate
n/a
Meas. Tech.
ChEMBL_2243004 (CHEMBL5157214)
IC50
<39811±n/a nM
Citation
 Humphreys, PG; Atkinson, SJ; Bamborough, P; Bit, RA; Chung, CW; Craggs, PD; Cutler, L; Davis, R; Ferrie, A; Gong, G; Gordon, LJ; Gray, M; Harrison, LA; Hayhow, TG; Haynes, A; Henley, N; Hirst, DJ; Holyer, ID; Lindon, MJ; Lovatt, C; Lugo, D; McCleary, S; Molnar, J; Osmani, Q; Patten, C; Preston, A; Rioja, I; Seal, JT; Smithers, N; Sun, F; Tang, D; Taylor, S; Theodoulou, NH; Thomas, C; Watson, RJ; Wellaway, CR; Zhu, L; Tomkinson, NCO; Prinjha, RK Design, Synthesis, and Characterization of I-BET567, a Pan-Bromodomain and Extra Terminal (BET) Bromodomain Oral Candidate. J Med Chem 65:2262-2287 (2022) [PubMed]  Article
Target
Name:
Cytochrome P450 3A4
Synonyms:
Albendazole monooxygenase | Albendazole sulfoxidase | CP3A4_HUMAN | CYP3A3 | CYP3A4 | CYPIIIA3 | CYPIIIA4 | Cytochrome P450 3A3 | Cytochrome P450 3A4 (CYP3A4) | Cytochrome P450 HLp | Nifedipine oxidase | Quinine 3-monooxygenase | Taurochenodeoxycholate 6-alpha-hydroxylase
Type:
Enzyme
Mol. Mass.:
57349.57
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
503
Sequence:
MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGA
  
Inhibitor
Name:
BDBM50603089
Synonyms:
CHEMBL5194720
Type:
Small organic molecule
Emp. Form.:
C18H19ClN4O2
Mol. Mass.:
358.822
SMILES:
C[C@H]1C[C@@H](Nc2ccc(Cl)cn2)c2cc(ccc2N1C(C)=O)C(N)=O |r|
Structure:
Search PDB for entries with ligand similarity: